Locations:
Search IconSearch

Cancer

22-NEU-2763298-060-CQD-Hero-650×450-v2
April 28, 2022/Cancer

Gamma Knife for Brain Tumors: Latest Developments and What’s on the Horizon

Two stereotactic radiosurgery experts take stock after Cleveland Clinic’s 10,000th case

22-CNR-2819722-CQD-Hero-650×450-1
April 27, 2022/Cancer/Blood Cancers

Hairy Cell Leukemia Complicated by Severe COVID-19: A Case Study

Novel three-drug regimen used to manage life-threatening developments

22-CNR-2800312-CQD-Hero-650×450-1
April 25, 2022/Cancer/Research

MCL1 in the Nucleus Appears to Drive Chemoresistance in Colorectal Cancer

Bcl-xL inhibitors may help overcome this complication

22-CNR-IV-Drip-CQD-Hero-650×450-1
April 20, 2022/Cancer/Tumor Oncology

Combination Chemo-Immunotherapy Appears to Improve Outcomes in Muscle-Invasive Bladder Cancer

New results from the BLASST-1 trial show increases in downstaging and relapse-free survival

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Rectal cancer cell
April 19, 2022/Cancer

Minimally Invasive Approach Is Advantageous for Rectal Cancer

Study compares open versus laparoscopic abdominoperineal resection outcomes

Mammary carcinoma with lobular features. Breast cancer
April 12, 2022/Cancer/Tumor Oncology

MRI May Be Best Tool for Tumor Staging and Detecting Bilateral Disease in Invasive Lobular Carcinoma

Study highlights value of preoperative imaging to guide surgical decision-making

Son holding father’s hand at the hospital
April 7, 2022/Cancer

Socioeconomic Disadvantage Is Associated With Increased Mortality After Radical Cystectomy

Study finds that post-cystectomy mortality and survival is associated with socioeconomic factors

22-DDI-2684108 ESD after TNT DIAGNOSIS Hero 650×450
April 5, 2022/Cancer

Total Neoadjuvant Therapy Followed by Endoluminal Submucosal Dissection for Colorectal Cancer: A Case Report

Case highlights potential benefits of this staged, dual-therapy approach

22-CNR-2775808-CQD-Hero-1-650×450-1
March 25, 2022/Cancer

New Study Highlights Prescribing Patterns in the Treatment of Advanced Urothelial Carcinoma

Physician interviews reveal increasing use of systemic therapy for Ia/mUC

22-CNR-2668718-CQD-Hero-650×450-1
March 23, 2022/Cancer/Blood Cancers

Experimental Drug Shows Promise for Alleviating Myelofibrosis-Associated Anemia

Momelotinib, a new JAK inhibitor, inches closer to market approval

BackPage 31 of 112Next

Advertisement

Ad